La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Eléments de l'association

P. Hantraye15
Parkinson maladie1501
P. Hantraye Sauf Parkinson maladie" 3
Parkinson maladie Sauf P. Hantraye" 1489
P. Hantraye Et Parkinson maladie 12
P. Hantraye Ou Parkinson maladie 1504
Corpus2807
\n\n\n\n \n

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
001198 N. W. Kowall [États-Unis] ; P. Hantraye [France] ; E. Brouillet [France] ; M. F. Beal [États-Unis] ; A. C. Mckee [États-Unis] ; R. J. Ferrante [États-Unis]MPTP induces alpha-synuclein aggregation in the substantia nigra of baboons
001273 P. Remy [France] ; P. Hantraye [France] ; Y. Samson [France]La tomographie par émission de positions, un outil de recherche fondamentale devenu indispensable à la recherche clinique : L'exemple des greffes neuronales dans la maladie de Parkinson
001331 R. J. Ferrante [États-Unis] ; P. Hantraye [France] ; E. Brouillet [France] ; M. F. Beal [États-Unis]Increased nitrotyrosine immunoreactivity in substantia nigra neurons in MPTP treated baboons is blocked by inhibition of neuronal nitric oxide synthase
001435 P. Hantraye [France]Modeling dopamine system dysfunction in experimental animals
001437 S. Palfi [France] ; J. P. Nguyen [France] ; P. Brugieres [France] ; C. Le Guerinel [France] ; P. Hantraye [France] ; P. Remy [France] ; S. Rostaing [France] ; G. L. Defer [France] ; P. Cesaro [France] ; Y. Keravel [France] ; M. Peschanski [France]MRI-stereotactical approach for neural grafting in basal ganglia disorders
001736 P. Remy [France] ; Y. Samson [France] ; P. Hantraye [France] ; A. Fontaine [France] ; G. Defer [France] ; J.-F. Mangin [France] ; G. Fenelon [France] ; C. Geny [France] ; F. Ricolfi [France] ; V. Frouin [France] ; J.-P. N'Guyen [France] ; R. Jeny [France] ; J.-D. Degos [France] ; M. Peschanski [France] ; P. Cesaro [France]Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients
001810 P. Hantraye [France] ; E. BrouilletChronic treatment with mitochondrial toxins in primates as experimental models of Parkinson's and Huntington's diseases
001811 M. Varastet [France] ; D. Riche [France] ; M. Maziere [France] ; P. Hantraye [France]Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease
001812 M. Peschanski [France] ; G. Defer [France] ; J. P. N'Guyen [France] ; F. Ricolfi ; J. C. Monfort ; P. Remy ; C. Geny [France] ; Y. Samson ; P. Hantraye ; R. Jeny ; A. Gaston ; Y. Keravel [France] ; J. D. Degos [France] ; P. Cesaro [France]Bilateral motor improvement and alteration of L-dopa effect in two patient with Parkinson's disease following intrastriatal transplantation of foetal ventral mesencephalon
001861 P. Hantraye [France] ; M. Varastet [France] ; M. Peschanski [France] ; D. Riche [France] ; P. Cesaro ; J. C. Willer ; M. Maziere [France]Stable Parkinsonian syndrome and uneven loss of striatal dopamine fibres following chronic MPTP administration in baboons
001B80 P. Hantraye ; B. Maziere ; M. Maziere ; H. Fukuda ; R. NaquetDopaminergic and benzodiazepine receptors studied in vivo by PET
001B83 P. Hantraye ; C. Loc'H ; U. Tacke ; D. Riche ; O. Stulzaft ; D. Doudet ; B. Guibert ; R. Naquet ; B. Maziere ; M. Maziere"In vivö visualization by positron emission tomography of the progressive striatal dopamine receptor damage occurring in MPTP-intoxicated non-human primates

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024